200 related articles for article (PubMed ID: 33806345)
1. Involvement of the Catecholamine Pathway in Glioblastoma Development.
Kraboth Z; Kajtár B; Gálik B; Gyenesei A; Miseta A; Kalman B
Cells; 2021 Mar; 10(3):. PubMed ID: 33806345
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation and protein expression of Wnt pathway markers in progressive glioblastoma.
Tompa M; Kajtar B; Galik B; Gyenesei A; Kalman B
Pathol Res Pract; 2021 Jun; 222():153429. PubMed ID: 33857857
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic Suppression of the IL-7 Pathway in Progressive Glioblastoma.
Tompa M; Kraboth Z; Galik B; Kajtar B; Gyenesei A; Kalman B
Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140275
[TBL] [Abstract][Full Text] [Related]
4. Integrative analysis of DNA methylation and gene expression to identify key epigenetic genes in glioblastoma.
Jia D; Lin W; Tang H; Cheng Y; Xu K; He Y; Geng W; Dai Q
Aging (Albany NY); 2019 Aug; 11(15):5579-5592. PubMed ID: 31395792
[TBL] [Abstract][Full Text] [Related]
5. DNA CpG methylation in sequential glioblastoma specimens.
Kraboth Z; Galik B; Tompa M; Kajtar B; Urban P; Gyenesei A; Miseta A; Kalman B
J Cancer Res Clin Oncol; 2020 Nov; 146(11):2885-2896. PubMed ID: 32779022
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation in glioblastoma: impact on gene expression and clinical outcome.
Etcheverry A; Aubry M; de Tayrac M; Vauleon E; Boniface R; Guenot F; Saikali S; Hamlat A; Riffaud L; Menei P; Quillien V; Mosser J
BMC Genomics; 2010 Dec; 11():701. PubMed ID: 21156036
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of TES by hypermethylation in glioblastoma reduces cell apoptosis and predicts poor clinical outcome.
Bai Y; Zhang QG; Wang XH
Eur J Med Res; 2014 Dec; 19(1):66. PubMed ID: 25498217
[TBL] [Abstract][Full Text] [Related]
8. Methylation regulates HEY1 expression in glioblastoma.
Tsung AJ; Guda MR; Asuthkar S; Labak CM; Purvis IJ; Lu Y; Jain N; Bach SE; Prasad DVR; Velpula KK
Oncotarget; 2017 Jul; 8(27):44398-44409. PubMed ID: 28574840
[TBL] [Abstract][Full Text] [Related]
9. Intratumor DNA methylation heterogeneity in glioblastoma: implications for DNA methylation-based classification.
Wenger A; Ferreyra Vega S; Kling T; Bontell TO; Jakola AS; Carén H
Neuro Oncol; 2019 May; 21(5):616-627. PubMed ID: 30668814
[TBL] [Abstract][Full Text] [Related]
10. MGMT expression and promoter methylation status may depend on the site of surgical sample collection within glioblastoma: a possible pitfall in stratification of patients?
Della Puppa A; Persano L; Masi G; Rampazzo E; Sinigaglia A; Pistollato F; Denaro L; Barzon L; Palù G; Basso G; Scienza R; d'Avella D
J Neurooncol; 2012 Jan; 106(1):33-41. PubMed ID: 21725802
[TBL] [Abstract][Full Text] [Related]
11. STAT6 expression in glioblastoma promotes invasive growth.
Merk BC; Owens JL; Lopes MB; Silva CM; Hussaini IM
BMC Cancer; 2011 May; 11():184. PubMed ID: 21595984
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic modulation of the drug resistance genes MGMT, ABCB1 and ABCG2 in glioblastoma multiforme.
Oberstadt MC; Bien-Möller S; Weitmann K; Herzog S; Hentschel K; Rimmbach C; Vogelgesang S; Balz E; Fink M; Michael H; Zeden JP; Bruckmüller H; Werk AN; Cascorbi I; Hoffmann W; Rosskopf D; Schroeder HW; Kroemer HK
BMC Cancer; 2013 Dec; 13():617. PubMed ID: 24380367
[TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation and down-regulation of TMS1/ASC in human glioblastoma.
Stone AR; Bobo W; Brat DJ; Devi NS; Van Meir EG; Vertino PM
Am J Pathol; 2004 Oct; 165(4):1151-61. PubMed ID: 15466382
[TBL] [Abstract][Full Text] [Related]
14. Proteins of the Wnt signaling pathway as targets for the regulation of CD133+ cancer stem cells in glioblastoma.
Shevchenko V; Arnotskaya N; Korneyko M; Zaytsev S; Khotimchenko Y; Sharma H; Bryukhovetskiy I
Oncol Rep; 2019 May; 41(5):3080-3088. PubMed ID: 30864699
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide methylation analyses in glioblastoma multiforme.
Lai RK; Chen Y; Guan X; Nousome D; Sharma C; Canoll P; Bruce J; Sloan AE; Cortes E; Vonsattel JP; Su T; Delgado-Cruzata L; Gurvich I; Santella RM; Ostrom Q; Lee A; Gregersen P; Barnholtz-Sloan J
PLoS One; 2014; 9(2):e89376. PubMed ID: 24586730
[TBL] [Abstract][Full Text] [Related]
16. Assessment of genetic markers and glioblastoma stem-like cells in activation of dendritic cells.
Yurtsever A; Haydaroglu A; Biray Avci C; Gunduz C; Oktar N; Dalbasti T; Caglar HO; Attar R; Kitapcioglu G
Hum Cell; 2013 Sep; 26(3):105-13. PubMed ID: 23737374
[TBL] [Abstract][Full Text] [Related]
17. Molecular markers of extracellular matrix remodeling in glioblastoma vessels: microarray study of laser-captured glioblastoma vessels.
Pen A; Moreno MJ; Martin J; Stanimirovic DB
Glia; 2007 Apr; 55(6):559-72. PubMed ID: 17266141
[TBL] [Abstract][Full Text] [Related]
18. CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme.
Martinez R; Setien F; Voelter C; Casado S; Quesada MP; Schackert G; Esteller M
Carcinogenesis; 2007 Jun; 28(6):1264-8. PubMed ID: 17272309
[TBL] [Abstract][Full Text] [Related]
19. Homeobox genes gain trimethylation of histone H3 lysine 4 in glioblastoma tissue.
Luo K; Luo D; Wen H
Biosci Rep; 2016 Jul; 36(3):. PubMed ID: 27160082
[TBL] [Abstract][Full Text] [Related]
20. Activation of Dopamine Receptor 2 Prompts Transcriptomic and Metabolic Plasticity in Glioblastoma.
Caragher SP; Shireman JM; Huang M; Miska J; Atashi F; Baisiwala S; Hong Park C; Saathoff MR; Warnke L; Xiao T; Lesniak MS; James CD; Meltzer H; Tryba AK; Ahmed AU
J Neurosci; 2019 Mar; 39(11):1982-1993. PubMed ID: 30651332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
